Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Tasanarong, Adis ^a   Hutayanon, Pisit ^a   Piyayotai, Dilok ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Chronic Kidney injury (CKD); Contrast Induced Acute Kidney Injury (CI AKI); Coronary procedures; Neutrophil Gelatinase Associated Lipocalin (NGAL)

Indexed keywords

CREATININE; IOPROMIDE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY SURGERY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; ELECTIVE SURGERY; ELISA KIT; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURGICAL PATIENT; URINALYSIS;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COMORBIDITY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THAILAND; YOUNG ADULT;

EID: 84889025990     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-270     Document Type: Article

References (37)

1. Nephrotoxicity of contrast media. Berns AS, Kidney Int 1989 36 4 730 740 10.1038/ki.1989.254 2681935 (Pubitemid 19239569)
2. Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention. Gurm HS, Smith DE, Berwanger O, Share D, Schreiber T, Moscucci M, Nallamothu BK, JACC Cardiovasc Interv 2012 5 1 98 104 10.1016/j.jcin.2011.09.019 22230155
3. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). ACT Investigators, Circulation 2011 124 11 1250 1259 21859972
4. Contrast-induced nephropathy: is the picture any clearer? Rudnick MR, Goldfarb S, Tumlin J, Clin J Am Soc Nephrol 2008 3 1 261 262 10.2215/CJN.04951107 18077780
5. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Rich MW, Crecelius CA, Arch Intern Med 1990 150 6 1237 1242 10.1001/archinte.1990.00390180067011 2353856 (Pubitemid 20188457)
6. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, et al. Am J Cardiol 2002 90 10 1068 1073 10.1016/S0002-9149(02) 02771-6 12423705 (Pubitemid 35335595)
7. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, et al. Am J Cardiol 2004 94 3 300 305 10.1016/j.amjcard.2004.04.023 15276092 (Pubitemid 38962693)
8. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB, J Am Coll Cardiol 2000 36 5 1542 1548 10.1016/S0735-1097(00)00917-7 11079656
9. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Thomsen HS, Morcos SK, Br J Radiol 2003 76 908 513 518 10.1259/bjr/26964464 12893691 (Pubitemid 37028403)
10. Contrast nephropathy after coronary angiography. Gami AS, Garovic VD, Mayo Clin Proc 2004 79 2 211 219 10.4065/79.2.211 14959916 (Pubitemid 38140805)
11. Defining acute renal failure: physiological principles. Bellomo R, Kellum JA, Ronco C, Intensive Care Med 2004 30 1 33 37 10.1007/s00134-003-2078-3 14618231 (Pubitemid 38147105)
12. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Bonventre JV, Contrib Nephrol 2007 156 213 219 17464130
13. Measured GFR as a confirmatory test for estimated GFR. Stevens LA, Levey AS, J Am Soc Nephrol 2009 20 11 2305 2313 10.1681/ASN.2009020171 19833901
14. Creatinine kinetics and the definition of acute kidney injury. Waikar SS, Bonventre JV, J Am Soc Nephrol 2009 20 3 672 679 10.1681/ASN.2008070669 19244578
15. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P, J Am Soc Nephrol 2003 14 10 2534 2543 10.1097/01.ASN.0000088027.54400.C6 14514731 (Pubitemid 37169339)
16. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury-where do we stand today? Schmidt-Ott KM, Nephrol Dial Transplant 2011 26 3 762 764 10.1093/ndt/gfr006 21310736
17. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P, Am J Nephrol 2004 24 3 307 315 10.1159/000078452 15148457 (Pubitemid 39070114)
18. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshioka T, Ogawa Y, Imamaki H, Kusakabe T, et al. Kidney Int 2009 75 3 285 294 10.1038/ki.2008.499 19148153
19. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT, Am J Kidney Dis 2008 52 3 425 433 10.1053/j.ajkd.2008.05.018 18649981
20. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P, Clin J Am Soc Nephrol 2008 3 3 665 673 10.2215/CJN.04010907 18337554
21. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL, Crit Care 2007 11 4 84 10.1186/cc6089 17678545 (Pubitemid 47262102)
22. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. Siew ED, Ware LB, Gebretsadik T, Shintani A, Moons KG, Wickersham N, Bossert F, Ikizler TA, J Am Soc Nephrol 2009 20 8 1823 1832 10.1681/ASN.2008070673 19628673
23. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, Edelstein CL, Devarajan P, Am J Transplant 2006 6 7 1639 1645 10.1111/j.1600-6143.2006.01352.x 16827865 (Pubitemid 43945804)
24. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, Devarajan P, Han WK, Marcus RJ, Parikh CR, J Am Soc Nephrol 2010 21 1 189 197 10.1681/ASN.2009030264 19762491
25. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH 3rd, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P, Pediatr Nephrol 2007 22 12 2089 2095 10.1007/s00467-007-0601-4 17874137 (Pubitemid 350090716)
26. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Pawlak K, Mysliwiec M, Lawnicki S, Szmitkowski M, Dobrzycki S, Kidney Blood Press Res 2007 30 6 408 415 10.1159/000109102 17901710 (Pubitemid 350191437)
27. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Ling W, Zhaohui N, Ben H, Leyi G, Jianping L, Huili D, Jiaqi Q, Nephron Clin Pract 2008 108 3 176 c181 10.1159/000117814 18287807 (Pubitemid 351588109)
28. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine. Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Adv Med Sci 2009 54 2 221 224 19875355
29. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, Ann Intern Med 2003 139 2 137 147 10.7326/0003-4819-139-2-200307150-00013 12859163
30. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, van Lente F, Ann Intern Med 2006 145 4 247 254 10.7326/0003-4819-145-4-200608150-00004 16908915 (Pubitemid 46768608)
31. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, et al. J Am Coll Cardiol 2004 44 7 1393 1399 15464318 (Pubitemid 39303939)
32. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Hanley JA, McNeil BJ, Radiology 1983 148 3 839 843 6878708 (Pubitemid 13033817)
33. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S, Ren Fail 2008 30 6 625 628 10.1080/08860220802134607 18661413
34. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M, Kidney Blood Press Res 2008 31 4 255 258 10.1159/000143726 18600028
35. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M, Clin J Am Soc Nephrol 2009 4 2 337 344 10.2215/CJN.03530708 19176795
36. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, Paragas N, Nicholas T, Devarajan P, Barasch J, Curr Opin Nephrol Hypertens 2006 15 4 442 449 10.1097/01.mnh.0000232886.81142.58 16775460 (Pubitemid 44297988)
37. NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Nickolas TL, Forster CS, Sise ME, Barasch N, Valle DS, Viltard M, Buchen C, Kupferman S, Carnevali ML, Bennett M, et al. Kidney Int 2012 82 6 718 722 10.1038/ki.2012.195 22695331